Teladoc Health, Inc. Peer Comparison
Metric | Value | Ranking | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $2.2 Billion | 3/9 | VEEV $37.9B |
DOCS $14.1B |
TDOC $2.2B |
PGNY $1.9B |
GDRX $1.8B |
SDGR $1.7B |
TXG $1.4B |
TALK $675.7M |
ACCD $563.6M |
Gross Margin | 72% | 4/9 | GDRX 94% |
DOCS 90% |
VEEV 75% |
TDOC 72% |
TXG 70% |
SDGR 50% |
TALK 46% |
ACCD 44% |
PGNY 21% |
Profit Margin | -5% | 6/9 | DOCS 32% |
VEEV 27% |
GDRX 6% |
PGNY 4% |
TALK -3% |
TDOC -5% |
TXG -24% |
SDGR -100% |
ACCD -100% |
EBITDA margin | -7% | 6/9 | DOCS 39% |
VEEV 26% |
GDRX 7% |
PGNY 4% |
TALK 0% |
TDOC -7% |
ACCD -15% |
TXG -16% |
SDGR -194% |
Quarterly Revenue | $640.5 Million | 2/9 | VEEV $699.2M |
TDOC $640.5M |
PGNY $286.6M |
GDRX $195.3M |
TXG $151.7M |
TALK $138.8M |
DOCS $136.8M |
ACCD $105.1M |
SDGR $35.3M |
Quarterly Earnings | -$33.3 Million | 6/9 | VEEV $185.8M |
DOCS $44.2M |
GDRX $12.3M |
PGNY $10.4M |
TALK -$3.6M |
TDOC -$33.3M |
TXG -$35.8M |
SDGR -$38.1M |
ACCD -$121.3M |
Quarterly Free Cash Flow | $168.8 Million | 1/9 | TDOC $168.8M |
VEEV $164.1M |
GDRX $123.6M |
DOCS $70.1M |
PGNY $42.7M |
TXG $17.8M |
TALK $4.6M |
ACCD -$7.8M |
SDGR -$34.6M |
Trailing 4 Quarters Revenue | $2.6 Billion | 2/9 | VEEV $2.7B |
TDOC $2.6B |
PGNY $1.1B |
GDRX $790.4M |
TXG $629.7M |
DOCS $516.8M |
ACCD $446.7M |
TALK $272.7M |
SDGR $193.3M |
Trailing 4 Quarters Earnings | -$981.7 Million | 9/9 | VEEV $699.2M |
TDOC $640.5M |
PGNY $286.6M |
GDRX $195.3M |
TXG $151.7M |
TALK $138.8M |
DOCS $136.8M |
ACCD $105.1M |
SDGR $35.3M |
Quarterly Earnings Growth | 42% | 4/9 | GDRX 132% |
TXG 62% |
DOCS 44% |
TDOC 42% |
SDGR 39% |
VEEV 37% |
TALK 19% |
PGNY -34% |
ACCD -476% |
Annual Earnings Growth | -289% | 9/9 | TALK 63% |
DOCS 50% |
VEEV 42% |
TXG 35% |
PGNY -6% |
ACCD -51% |
GDRX -106% |
SDGR -261% |
TDOC -289% |
Quarterly Revenue Growth | -3% | 8/9 | TALK 259% |
DOCS 20% |
VEEV 13% |
GDRX 8% |
ACCD 6% |
PGNY 2% |
TXG -1% |
TDOC -3% |
SDGR -17% |
Annual Revenue Growth | -1% | 9/9 | TALK 87% |
SDGR 31% |
DOCS 18% |
ACCD 15% |
VEEV 11% |
TXG 6% |
GDRX 6% |
PGNY 2% |
TDOC -1% |
Cash On Hand | $1.2 Billion | 1/9 | TDOC $1.2B |
VEEV $1.0B |
GDRX $423.8M |
TXG $398.2M |
ACCD $185.9M |
DOCS $184.2M |
SDGR $160.4M |
TALK $119.0M |
PGNY $91.5M |
Short Term Debt | $550.7 Million | 1/9 | TDOC $550.7M |
SDGR $16.9M |
ACCD $14.7M |
TXG $9.4M |
GDRX $9.3M |
VEEV $9.2M |
DOCS $2.2M |
PGNY -$0 |
TALK -$0 |
Long Term Debt | $1.6 Billion | 1/9 | TDOC $1.6B |
SDGR $103.3M |
TXG $76.5M |
VEEV $62.5M |
GDRX $47.7M |
ACCD $21.1M |
PGNY $16.6M |
DOCS $11.3M |
TALK $0 |
PE | -1.00 | 4/9 | DOCS 81.02 |
VEEV 56.89 |
PGNY 32.74 |
TDOC -1.00 |
TXG -1.00 |
SDGR -1.00 |
ACCD -1.00 |
GDRX -1.00 |
TALK -1.00 |
PS | 0.83 | 9/9 | DOCS 27.29 |
VEEV 14.26 |
SDGR 8.98 |
TALK 2.48 |
GDRX 2.33 |
TXG 2.27 |
PGNY 1.65 |
ACCD 1.26 |
TDOC 0.83 |
PB | 1.43 | 9/9 | DOCS 14.68 |
VEEV 6.89 |
TALK 5.75 |
PGNY 4.31 |
SDGR 3.86 |
GDRX 2.64 |
TXG 1.98 |
ACCD 1.80 |
TDOC 1.43 |
PC | 1.74 | 9/9 | DOCS 76.56 |
VEEV 36.27 |
PGNY 20.50 |
SDGR 10.83 |
TALK 5.68 |
GDRX 4.34 |
TXG 3.59 |
ACCD 3.03 |
TDOC 1.74 |
Liabilities to Equity | 1.34 | 1/9 | TDOC 1.34 |
ACCD 1.07 |
GDRX 0.95 |
PGNY 0.52 |
SDGR 0.49 |
TXG 0.30 |
TALK 0.18 |
VEEV 0.17 |
DOCS 0.16 |
ROA | -0.28 | 8/9 | DOCS 16% | VEEV 10% | PGNY 9% | GDRX -1% | TALK -5% | TXG -19% | SDGR -27% | TDOC -28% | ACCD -28% |
ROE | -0.65 | 9/9 | DOCS 18% |
PGNY 13% |
VEEV 12% |
GDRX -1% |
TALK -6% |
TXG -25% |
SDGR -40% |
ACCD -58% |
TDOC -65% |
Current Ratio | 1.75 | 9/9 | DOCS 7.11 |
VEEV 6.78 |
TALK 6.70 |
TXG 4.36 |
SDGR 3.04 |
PGNY 2.93 |
GDRX 2.06 |
ACCD 1.94 |
TDOC 1.75 |
Quick Ratio | 0.62 | 9/9 | DOCS 81.02 |
VEEV 56.89 |
PGNY 32.74 |
TDOC -1.00 |
TXG -1.00 |
SDGR -1.00 |
ACCD -1.00 |
GDRX -1.00 |
TALK -1.00 |
Long Term Debt to Equity | 1.05 | 1/9 | TDOC} 1.05 |
SDGR} 0.23 |
TXG} 0.11 |
ACCD} 0.07 |
GDRX} 0.07 |
PGNY} 0.04 |
VEEV} 0.01 |
DOCS} 0.01 |
TALK} 0.00 |
Debt to Equity | 1.05 | 1/9 | TDOC 1.05 |
SDGR 0.27 |
TXG 0.12 |
ACCD 0.09 |
GDRX 0.08 |
PGNY 0.04 |
VEEV 0.01 |
DOCS 0.01 |
TALK 0.00 |
Burn Rate | 5.31 | 3/9 | TALK 33.10 |
TXG 9.67 |
TDOC 5.31 |
SDGR 3.45 |
ACCD 1.48 |
DOCS -4.27 |
VEEV -5.77 |
PGNY -9.38 |
GDRX -52.78 |
Cash to Cap | 0.58 | 1/9 | TDOC 0.58 |
ACCD 0.33 |
TXG 0.28 |
GDRX 0.23 |
TALK 0.18 |
SDGR 0.09 |
PGNY 0.05 |
VEEV 0.03 |
DOCS 0.01 |
CCR | -5.07 | 9/9 | GDRX 10.08 |
PGNY 4.10 |
DOCS 1.59 |
SDGR 0.91 |
VEEV 0.88 |
ACCD 0.06 |
TXG -0.50 |
TALK -1.28 |
TDOC -5.07 |
EV to EBITDA | -56.19 | 9/9 | TALK} 5623.21 |
DOCS} 262.24 |
VEEV} 203.53 |
PGNY} 144.50 |
GDRX} 110.90 |
SDGR} -24.80 |
ACCD} -25.69 |
TXG} -47.23 |
TDOC} -56.19 |
EV to Revenue | 0.96 | 8/9 | DOCS 26.96 |
VEEV 13.89 |
SDGR 8.78 |
TALK 2.04 |
GDRX 1.87 |
TXG 1.78 |
PGNY 1.58 |
TDOC 0.96 |
ACCD 0.91 |